ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GYG Gyg Plc

30.00
0.00 (0.00%)
21 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gyg Plc LSE:GYG London Ordinary Share GB00BZ4FM652 ORD GBP0.002
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 30.00 25.00 45.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Board Change

02/01/2004 11:10am

UK Regulatory


RNS Number:7820T
Gyrus Group PLC
02 January 2004

                                                                  2 January 2004

                                 Gyrus Group PLC

                Confirmation of Board changes at Gyrus Group PLC


Reading, UK - Gyrus Group (GYG.L) a leading supplier of medical devices to
reduce trauma and complications in surgery, today confirms that the changes to
its Board of Directors that were announced in detail in September, 2003 have
taken effect as follows:


Simon Shaw has been appointed to the Board with effect from 1 January 2004.
Also with effect from 1 January, Tom Murphy resigns as Finance Director to
return to the US to take up his new appointment within the Group as President of
Gyrus Medical Inc. Tom Murphy has served as group Finance Director since 2001
and during his tenure has played a key role in the development of Gyrus through
the acquisition of a number of businesses and the day-to-day financial
management of the Group.


Simon Shaw, aged 38, joined Gyrus on 1 October, 2003 as Chief Financial Officer.
He has financial and management experience gained both in the City and Industry.
His last post was Chief Operating Officer of  Profile Therapeutics plc a medical
devices business, which he joined in 1997 and was responsible for its flotation
in 2000. Prior to that he was a corporate financier with Hambros Bank Limited,
and previously WestLB, where he advised on flotations, fund raisings and
international mergers and acquisitions. He qualified as a Chartered Accountant
with Arthur Andersen & Co. in 1990.


Simon Shaw was a director of Profile Therapeutics plc, from July 1997 to April
2003.  Gyrus can advise that there are no further details relating to the
appointment of Simon Shaw which it is obliged to disclose under paragraph 6.F.2.
(b-g) of the Listing Rules of the UK Listing Authority.


Enquiries:


Gyrus:
Brian Steer, Executive Chairman                 Today                 07768 686 190
                                                Thereafter            01189 219 750
Simon Shaw, Chief Financial Officer             Today                 07739 807 625
                                                Thereafter            01189 219 750

Financial Dynamics:
Ben Atwell                                                            0207 831 3113


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOADGGGMGZNGDZM

1 Year Gyg Chart

1 Year Gyg Chart

1 Month Gyg Chart

1 Month Gyg Chart

Your Recent History

Delayed Upgrade Clock